Trillions of bacteria and other microbes live in the human body. The mouth and the gut in particular, are microbial hot spots at either end of the digestive tract. Every day, humans swallow around 1.5 liters of saliva, along with millions of oral microbes. Scientists believe that more than 99% of these microbes die as they pass through the acidic environment of the stomach and later the small intestine, which act as a barrier between the bacteria of the mouth and gut.

Failure of this barrier can lead to overgrowth of oral microbes in the gut. This may contribute to diseases like bowel cancer, rheumatoid arthritis and inflammatory bowel diseases. But even in healthy people, low levels of microbes usually found in the mouth are often found in stool. It is unclear if these microbes cross the barrier or if they are similar microbes that originate in the gut.

Now, Schmidt, Hayward et al. show that in healthy people at least one in three oral microbial cells pass through the digestive tract to settle the gut in healthy people. This challenges the notion of a mouth-gut barrier. In the experiments, the genetic material of all the microbes in the saliva and stool of several hundred people from three continents was analyzed. This allowed Schmidt, Hayward et al. to determine whether strains found in the gut originate from the mouth, or are closely related but specialized gut types of the same species. The results also showed that patients with bowel cancer and rheumatoid arthritis had more mouth-to-gut microbial transmission than their healthy counterparts.

The experiments suggest that the mouth is a microbial reservoir that constantly replenishes the gut flora. Some of the gut-traveling oral bacteria trigger inflammation when they grow in other parts of the body like the lining of the heart. This, along with the discovery that patients with certain diseases have more oral bacteria in the gut, may suggest that the transmission of these microbes contributes to disease. The experiments also indicate that finding ways to influence oral bacteria might affect the ones in the gut. More studies are needed to understand how mouth microbes survive the trip to the gut and are able to thrive in this competitive environment, and what role they play in health and disease.

Both the oral cavity and large intestine accommodate unique microbiomes that are relevant to human health and disease (Lynch and Pedersen, 2016; Wade, 2013). Mouth and gut are linked by a constant flow of ingested food and saliva along the gastrointestinal tract (GIT), yet they host distinct microbial communities (Ding and Schloss, 2014; Segata et al., 2012) in distinct microenvironments (Savage, 1977), and have been reported to harbor locally adapted strains (Lloyd-Price et al., 2017).

The segregation of oral and intestinal communities is thought to be maintained by various mechanisms, such as gastric acidity (Howden and Hunt, 1987; Martinsen et al., 2005) and antimicrobial bile acids in the duodenum (Ridlon et al., 2014). Failure of this oral-gut barrier has been proposed to lead to intestinal infection (Martinsen et al., 2005), and the prolonged usage of proton pump inhibitors can result in an enrichment of particular oral microbes in the gut (Imhann et al., 2016). Increased presence of specific oral taxa in the intestine has in turn been linked to several diseases, including rheumatoid arthritis (Zhang et al., 2015), colorectal cancer (Flynn et al., 2016; Zeller et al., 2014) and inflammatory bowel disease (IBD, (Gevers et al., 2014)). While it remains unclear whether disease-associated strains are indeed acquired endogenously (from the oral cavity) or from the environment, it was recently shown that Klebsiella strains originating from salivary samples of two IBD patients triggered intestinal inflammation in gnotobiotic mice (Atarashi et al., 2017).

This suggests that the presence of oral commensals in the gut is a rare, aberrant event as a consequence of ectopic colonization (i.e., ‘in the wrong place’), and hence a hallmark of disease. Outside a disease context, however, possible links between the oral and gut microbiome remain poorly characterized. Several genera were shown to be prevalent at both sites (Segata et al., 2012), with community types in one being weakly predictive of the other (Ding and Schloss, 2014), and with similar gene content in particular species (Franzosa et al., 2014), but with distinct, locally adapted strains (Lloyd-Price et al., 2017). We hypothesized that this picture is incomplete, and that microbial transmission along the GIT is more common than previously appreciated: that despite oral-gut barrier effects, some microbes freely and frequently traverse the GIT and colonize different niches, forming continuous populations that shape the human microbiome.

To test this hypothesis, we assembled and analyzed a dataset of 753 public and 182 newly sequenced saliva and stool metagenomes from 470 healthy and diseased individuals (diagnosed with rheumatoid arthritis, colorectal cancer or type-1 diabetes) from Fiji (Brito et al., 2016), China (Zhang et al., 2015), Luxembourg (Heintz-Buschart et al., 2016), France (Zeller et al., 2014), and Germany (Voigt et al., 2015) (see Materials and methods, Figure 1, and Supplementary file 1). For these samples we profiled 310 prevalent species, accounting for 99% of classifiable microbial abundance in both saliva and stool (see Materials and methods and Supplementary file 2). We reasoned that if transmission between the oral and gut microenvironments is frequent, we would expect salivary and fecal microbial populations to be more similar within an individual than between individuals. Conversely, under a strong barrier model with restricted transmission, intra- and inter-individual similarities would be equivalent.

Figure 1 with 1 supplement see all

Download asset Open asset

We found that at species level, community composition was consistent with distinct populations occupying the oral and intestinal microenvironments. By prevalence across subjects, the 310 profiled species fell into three categories (Figure 2A): 44% were predominantly fecal (observed in ≥10% of fecal, but <10% of saliva samples), including core members of the gut microbiome, such as Clostridium sp., Ruminococcus sp. and Bacteroides sp.; 16% of species were predominantly oral. Although the remaining 125 (40%) species were prevalent in ≥10% of saliva and stool samples, their relative abundances differed greatly between the two habitats. The overall oral and fecal microbiome compositions appeared independent of each other (between-subject Bray-Curtis dissimilarities per site, ρ_Pearson=-0.03), and the compositional overlap between mouth and gut of the same subject was not found to be significantly different when compared to a between-subject background (Wilcoxon test, Bray-Curtis dissimilarities, p=0.46).

Figure 2 with 5 supplements see all

Download asset Open asset

However, to accurately establish and quantify microbial transmission, it is necessary to track populations at the resolution of strains rather than species, as demonstrated previously in fecal microbiota transplantation (Li et al., 2016) or seeding of the infant microbiome (Asnicar et al., 2017); Korpela et al., 2018). We therefore profiled microbial single nucleotide variants (SNVs) across metagenomes, as a proxy for strain populations (Li et al., 2016). We formulated a transmission score for each species per subject, based on the likelihood that the observed intra-individual SNV overlap was generated by an inter-individual background model (see Materials and methods). Of the 125 species prevalent in both mouth and gut, 77% showed evidence of oral-fecal transmission. Out of these, 74 species (59%) showed significantly higher intra-individual SNV similarity across all subjects compared to cohort-wide background SNV frequencies (Benjamini-Hochberg-corrected Wilcoxon tests on transmission scores, p<0.05, see Materials and methods; Figure 2B, Figure 2—figure supplement 1, Supplementary file 2). This suggests that they form coherent strain populations along the GIT in most subjects, subject to frequent oral-fecal microbial transmission. Strains of Streptococcus, Veillonella, Actinomyces and Haemophilus, among other core oral taxa, fell into this category. An additional 22 species (18%) showed evidence of at least occasional transmission, with individually significant oral-fecal SNV overlap in some, but not across all subjects, as did 18 species that were generally prevalent in either the mouth or the gut (but not both). All 21 members of the Prevotella genus, an important clade of the gut microbiome, were among these occasionally transmitted species. The remaining 29 (23%) species, which were prevalent in both sites, did not show signs of transmission under the strict thresholds we applied.

The fecal abundance of all species with paired observations exceeded lower-bound physiologically predicted levels (i.e., the detection of salivary bacteria in stool purely as the result of ingestion) by several orders of magnitude, even with conservative estimates (Figure 1C, Figure 1—figure supplement 1). An average person swallows an estimated 1.5 * 10¹² oral bacteria per day (Humphrey and Williamson, 2001; Sender et al., 2016). Passage through the stomach reduces the viable bacterial load by 5–6 orders of magnitude (Giannella et al., 1972; Sender et al., 2016), a reduction that is expected to be mirrored at the DNA level, given that free DNA, released from dead bacterial cells, is degraded within seconds to minutes in saliva, the stomach and the intestine (see for example Mercer et al., 1999 and Liu et al., 2015). Relative to the ~3.8*10¹³ bacterial cells in the large intestine, ‘passive’ transmission without subsequent colonization in the gut would therefore account for a reduction in relative abundance by ~4*10⁻⁷ from saliva to feces (Figure 1C). Thus, the observed overlap of microbial SNVs could not be explained by passive translocation, but was indeed caused by active colonization in the gut. Moreover, transmission scores across species and subjects were independent of technical covariates, such as the horizontal or vertical coverage of genome mappings (Figure 2—figure supplement 2). Average transmission scores across subjects did not correlate with prevalence in stool across all taxa (ρ_Spearman =0.05), whereas an association was evident when considering only transmitters (ρ=0.67). In saliva, prevalence was globally indicative of transmission scores (ρ=0.6), reinforcing the notion that core oral taxa tended to be transmitted. Given the limited microbial read depth of salivary metagenomes (due to high fractions of human DNA), this result also indicates that our estimates of oral-fecal transmissibility were quite conservative, with potentially high rates of false negatives.

It was recently shown that during early life, infants are colonized by maternal strains from both the oral cavity and gut (Ferretti et al., 2018), and that strains from the latter can persist in the infant gut at least into childhood (Korpela et al., 2018). Therefore, to determine whether the observed intra-individual overlap of selected strain populations was due to continuous oral-gut transmission or rare colonization events with subsequent independent expansion in each site, we focused on a subset of 46 individuals for whom longitudinal data was available (with sampling intervals ranging from 1 week to >1 year; mean 79 days). We found that both oral and fecal strain populations were usually stable, even over extended periods of time (Figure 2—figure supplement 3), in line with earlier observations for each individual body site (Lloyd-Price et al., 2017; Schloissnig et al., 2013). Oral and fecal longitudinal SNV patterns were coupled for transmitted species (see Materials and methods): oral SNVs observed at an initial time point were significantly enriched among fecal SNVs that were newly gained over time, but generally not vice versa (Figure 2—figure supplement 4). Moreover, oral-fecal transmission rates (i.e., the fraction of fecal strain turnover attributable to oral strains; see Materials and methods) significantly exceeded background expectation for frequently transmitted taxa (Figure 2C). These findings orthogonally support the oral-gut transmission hypothesis as they strongly suggest that transmission is in the direction of mouth to gut, and not vice versa; and they imply that oral-intestinal transmission is indeed a frequent and continuous process in which oral strain populations constantly re-colonize the gut.

Oral-fecal transmissibility, as a trait, generally aligned with phylogenetic clade boundaries (phylogenetic signal, λ_Pagel=0.76), although transmitting groups were found across bacterial phyla (Figure 2DE, Figure 2—figure supplement 1, Supplementary file 2). Transmission scores were negatively correlated with genome size (ρ_Spearman=-0.6), indicating that transmitted species generally had smaller genomes than non-transmitted ones. Moreover, oxygen tolerant species (aerobes and facultative anaerobes) showed 7-fold higher scores than anaerobes on average (ANOVA, p=10⁻¹⁶). In contrast, no association was observed for sporulation and motility. To account for possible bias in the species reference and the phylogenetic signal of oral-fecal transmissibility, we confirmed that these signals were robust to phylogenetic regression (Supplementary file 2).

Viewed across individuals, we found that seeding of the gut microbiome from the oral cavity was extensive, with high levels of variation (Figure 3A). On average, potentially transmissible species (i.e., frequent and occasional transmitters) accounted for 75% of classifiable microbes in saliva, ranging up to 99% in some subjects. However, not all of these were detectable in the matched fecal samples, and oral-fecal strain overlap was generally incomplete. We therefore quantified the fraction of realized transmission based on paired observations of species and intra-individual SNV overlap (see Materials and methods). With these criteria, on average 35% of classifiable salivary microbes were transmitted strains that could be traced from mouth to gut within subjects. Similarly, on average 45% (range 2–95%) of classifiable fecal microbes were potential transmitters. These included common fecal species (e.g., Prevotella copri) that were detectable in a subset of salivary samples and showed only occasional transmission. Nevertheless, on average only 2% of classifiable fecal microbes could be confidently ascribed to transmitted strains, ranging to >30% in some subjects.

Figure 3 with 1 supplement see all

Download asset Open asset

Between-subject variation in the relative abundance of transmitted oral and fecal microbes was found to be independent of subject sex, age and body mass index, although moderate differences were observed between study cohorts (ANOVA, p=0.002; Figure 3B; Supplementary file 3). Levels of transmitted microbial abundance in mouth and gut were found to correlate with each other (ρ_Spearman=0.48) and with fecal species richness, but salivary transmitted abundance negatively correlated with oral species richness. This is in line with the observation that core oral species are transmissible, with higher richness implying the increased presence of non-transmitted taxa. Conversely, transmission would add species to a mostly non-transmissible core community in the gut.

Although there was no overall association to community composition, levels of transmission correlated with oral or fecal abundances of individual genera (Supplementary file 3). To test whether specific oral and gut microbiome features were predictive of transmission, we categorized individuals based on total transmitted abundance in saliva and stool as ‘high’ or ‘low’ transmission individuals (Materials and methods). We found that models based on salivary species abundances were mildly predictive of both oral (AUC = 0.738) and fecal (AUC = 0.642) transmission levels (Supplementary file 4, Figure 3—figure supplement 1). Gut species models, in contrast, were very strong predictors of transmission in both mouth (AUC = 0.951) and gut (AUC = 0.971). This signal was largely driven by the enrichment of transmitting species in stool (Supplementary file 4), but surprisingly robust to an elimination of all detected transmitters from the model (AUC = 0.835 for the stool transmission group), again implying that the true extent of oral-intestinal transmission may indeed exceed our conservative estimates. Fusobacterium nucleatum subsp. animalis and nucleatum stood out among non-trivial gut markers enriched in high-transmission individuals, in line with existing hypotheses that Fusobacterium nucleatum subspecies may enable synergistic colonization of oral bacteria in the gut, in association with certain diseases (see for example Flynn et al., 2016).

In general, the fecal enrichment of specific oral microbes has repeatedly been associated with various diseases (Zeller et al., 2014; Zhang et al., 2015). However, due to insufficient taxonomic resolution, oral provenance has so far remained impossible to distinguish from an influx of closely related but distinct strains from the environment. We therefore defined a list of disease states with putative links to oral-fecal transmission and annotated known associations in the literature to all species in our dataset (Figure 4A; Supplementary file 2). Transmission scores were significantly increased for known opportunistic pathogens (ANOVA, p=0.016), causative agents of dental caries (p=10⁻⁹), and plaque-dwelling bacteria (p=0.002). Likewise, species associated with periodontitis showed increased evidence for transmission (p=0.002), though this signal was mostly due to mildly periodontic species, while core drivers, such as Tannerella forsythia, Treponema denticola and Porphyromonas gingivalis (Socransky et al., 1998), showed little or no indication of oral-fecal transmission. Endocarditis-associated species showed significantly increased transmission scores upon phylogenetic regression (p=0.007), mostly driven by Haemophilus, Aggregatibacter and viridans Streptococci. This overall elevated transmissibility of taxa known to colonize ectopically in various habitats across the body (i.e., opportunistic pathogens), in particular via the bloodstream and associated with inflammation (i.e., endocarditis- or periodontitis-associated species (Hajishengallis, 2015)), may provide first cues to possible mechanisms of oral-fecal transmission.

Figure 4 with 1 supplement see all

Download asset Open asset

Our dataset included metagenomes from case-control studies for rheumatoid arthritis (RA, (Zhang et al., 2015)), colorectal cancer (CRC, (Zeller et al., 2014)) and type-1 diabetes (T1D, (Heintz-Buschart et al., 2016)), totaling 299 individuals, including 172 with salivary and fecal samples. Treatment-naïve CRC patients, sampled before colonoscopy, showed increased transmission scores across all taxa (average per-taxon Cohen’s d = 0.27; ANOVA p=10⁻²³; Figure 4B), as well as for transmitted taxa only (d = 0.23; p=10⁻¹⁰). The effect was even more pronounced for species previously described (Zeller et al., 2014) to be enriched in the feces of CRC patients (d = 0.33; p=10⁻⁴; Figure 4—figure supplement 1), including Fusobacterium nucleatum spp., Parvimonas micra and Peptostreptococcus stomatis. These findings are in line with a recent report that the oral and fecal microbiome are linked in the context of CRC (Felmer et al., 2018), and support the hypothesis (Flynn et al., 2016) that CRC-associated species are sourced intra-individually from the oral cavity.

Treatment-naïve RA patients displayed mildly elevated transmissibility across all taxa (d = 0.03, p=0.01) and transmissible taxa only (d = 0.07, p=0.08). Interestingly, species that were orally depleted in RA patients showed markedly increased transmission scores (d = 0.61; p=10⁻²¹). In contrast, a trend towards decreased transmission in T1D patients was not statistically significant.

Our results demonstrate that influx of oral strains from phylogenetically diverse microbial taxa into the gut microbiome is extensive in healthy individuals, with a high degree of variation between subjects. We showed that the vast majority of species prevalent in both the oral cavity and gut form connected strain populations along the gastrointestinal tract. Furthermore, by leveraging longitudinal data, we established that transmission from the mouth to the gut is a constant process. Approximately one in three classifiable salivary microbial cells colonize in the gut, accounting for at least 2% of the classifiable microbial abundance in feces. This puts oral-fecal transmission well in the range of other factors that determine human gut microbiome composition (Schmidt et al., 2018). Moreover, we note that by using saliva and feces as metagenomic readouts, we may underestimate colonization by oral microbes of the mucosa, given that fecal microbiome composition is not fully representative of the gastrointestinal tract (see for example Zmora et al., 2018). Therefore, and considering that our estimates of both the number of transmissible species and of the fraction of transmissible microbial abundance are conservative lower bounds due to strict thresholding and current detection limits of metagenomic sequencing, we posit that true levels of transmission are likely even higher, and that virtually all known oral species can translocate to the intestine at least under some circumstances.

Finally, we found increased transmission linked to some diseases, and showed for colorectal cancer and rheumatoid arthritis that disease-associated strains of several species enriched in the intestine are indeed sourced endogenously, that is from the patient’s oral cavity, and not from the environment. These results may extend to other diseases beyond those tested here, calling for revised models of microbiome-disease associations that consider the gastrointestinal microbiome as a whole rather than a sum of parts, with important implications for disease prevention, diagnosis, and (microbiome-modulating or -modulated) therapy.

While our findings are observational and do not reveal oral-intestinal transmission routes or mechanistic insights, they challenge current ecological and physiological models of the gastrointestinal tract that assume the oral cavity and large intestine to harbour mostly independent and segregated microbial communities. Instead, most strain populations appear to be continuous along the gastrointestinal tract, originating from the oral cavity, an underappreciated reservoir for the gut microbiome in health and disease.

Raw sequencing data have been deposited in the European Nucleotide Archive under project accessions PRJNA289586 and PRJEB28422.

1. 1. Schmidt TSB
   2. Hayward MR
   3. Coelho LP
   4. Li SS
   5. Costea PI

   (2018) European Nucleotide Archive

   ID PRJEB28422. The Salivary Microbiome in Health and Disease.

   https://www.ebi.ac.uk/ena/data/view/PRJEB28422
2. 1. Schmidt TSB
   2. Hayward MR
   3. Coelho LP
   4. Li SS
   5. Costea PI
   6. Voigt AY
   7. Maistrenko OM
   8. Alves RJ
   9. Bergsten E
   10. de Beaufort C
   11. Sobhani I
   12. Heintz-Buschart A
   13. Sunagawa S
   14. Zeller G
   15. Wilmes P
   16. Bork P

   (2018) European Nucleotide Archive

   ID PRJNA289586. Human Gut Microbiome in a Multiplex Family Study of Type 1 Diabetes Mellitus.

   https://www.ebi.ac.uk/ena/data/view/PRJNA289586

1. 1. Zhang X
   2. Zhang D
   3. Jia H
   4. Feng Q
   5. Wang D
   6. Liang D
   7. Wu X
   8. Li J
   9. Tang L
   10. Li Y
   11. Lan Z
   12. Chen B
   13. Zhong H
   14. Xie H
   15. Jie Z
   16. Chen W
   17. Tang S
   18. Xu X
   19. Wang X
   20. Cai X
   21. Liu S
   22. Xia Y
   23. Qiao X
   24. Al-Aama JY
   25. Chen H
   26. Wang L
   27. Wu QJ
   28. Zhang F
   29. Zheng W
   30. Zhang M
   31. Luo G
   32. Xue W
   33. Xiao L
   34. Yin Y
   35. Yang H
   36. Wang J
   37. Kristiansen K
   38. Liu L
   39. Li T

   (2015) European Nucleotide Archive

   ID PRJEB6997. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment.

   https://www.ebi.ac.uk/ena/data/view/PRJEB6997
2. 1. Brito IL
   2. Yilmaz S
   3. Huang K
   4. Xu L
   5. Jupiter SD
   6. Jenkins AP
   7. Naisilisili W
   8. Tamminen M
   9. Smillie CS
   10. Wortman JR
   11. Birren BW
   12. Xavier RJ
   13. Blainey PC
   14. Singh AK
   15. Gevers D

   (2016) European Nucleotide Archive

   ID PRJNA217052. FijiCOMP: saliva and stool metagenomes.

   https://www.ebi.ac.uk/ena/data/view/PRJNA217052
3. 1. Voigt AY
   2. Costea PI
   3. Kultima JR
   4. Li SS
   5. Zeller G
   6. Sunagawa S

   (2015) European Nucleotide Archive

   ID PRJEB8347. Temporal and technical variability of human gut metagenomes.

   https://www.ebi.ac.uk/ena/data/view/PRJEB8347
4. 1. Zeller G
   2. Tap J
   3. Voigt AY
   4. Sunagawa S
   5. Kultima JR
   6. Costea PI
   7. Amiot A
   8. Böhm J
   9. Brunetti F
   10. Habermann N
   11. Hercog R
   12. Koch M
   13. Luciani A
   14. Mende DR
   15. Schneider MA
   16. Schrotz-King P
   17. Tournigand C
   18. Tran Van Nhieu J
   19. Yamada T
   20. Zimmermann J
   21. Benes V

   (2014) European Nucleotide Archive

   ID PRJEB6070. Potential of fecal microbiota for early-stage detection of colorectal cancer.

   https://www.ebi.ac.uk/ena/data/view/PRJEB6070
5. 1. Heintz-Buschart A
   2. May P
   3. Laczny CC
   4. Lebrun LA
   5. Bellora C
   6. Krishna A

   (2016) European Nucleotide Archive

   ID PRJNA289586. Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes.

   https://www.ebi.ac.uk/ena/data/view/PRJNA289586

1. 1. Asnicar F
   2. Manara S
   3. Zolfo M
   4. Truong DT
   5. Scholz M
   6. Armanini F
   7. Ferretti P
   8. Gorfer V
   9. Pedrotti A
   10. Tett A
   11. Segata N

   (2017) Studying vertical microbiome transmission from mothers to infants by Strain-Level metagenomic profiling

   mSystems 2:e00164.

   https://doi.org/10.1128/mSystems.00164-16

   • PubMed
   • Google Scholar
2. 1. Atarashi K
   2. Suda W
   3. Luo C
   4. Kawaguchi T
   5. Motoo I
   6. Narushima S
   7. Kiguchi Y
   8. Yasuma K
   9. Watanabe E
   10. Tanoue T
   11. Thaiss CA
   12. Sato M
   13. Toyooka K
   14. Said HS
   15. Yamagami H
   16. Rice SA
   17. Gevers D
   18. Johnson RC
   19. Segre JA
   20. Chen K
   21. Kolls JK
   22. Elinav E
   23. Morita H
   24. Xavier RJ
   25. Hattori M
   26. Honda K

   (2017) Ectopic colonization of oral bacteria in the intestine drives T_H1 cell induction and inflammation

   Science 358:359–365.

   https://doi.org/10.1126/science.aan4526

   • PubMed
   • Google Scholar
3. 1. Brito IL
   2. Yilmaz S
   3. Huang K
   4. Xu L
   5. Jupiter SD
   6. Jenkins AP
   7. Naisilisili W
   8. Tamminen M
   9. Smillie CS
   10. Wortman JR
   11. Birren BW
   12. Xavier RJ
   13. Blainey PC
   14. Singh AK
   15. Gevers D
   16. Alm EJ

   (2016) Mobile genes in the human microbiome are structured from global to individual scales

   Nature 535:435–439.

   https://doi.org/10.1038/nature18927

   • PubMed
   • Google Scholar
4. 1. Coelho LP
   2. Alves R
   3. Monteiro P
   4. Huerta-Cepas J
   5. Freitas AT
   6. Bork P

   (2018) NG-meta-profiler: fast processing of metagenomes using NGLess a domain-specific language

    bioRxiv.

   https://doi.org/10.1101/367755

   • Google Scholar
5. 1. Costea PI
   2. Munch R
   3. Coelho LP
   4. Paoli L
   5. Sunagawa S
   6. Bork P

   (2017) metaSNV: a tool for metagenomic strain level analysis

   PLOS ONE 12:e0182392.

   https://doi.org/10.1371/journal.pone.0182392

   • PubMed
   • Google Scholar
6. 1. Ding T
   2. Schloss PD

   (2014) Dynamics and associations of microbial community types across the human body

   Nature 509:357–360.

   https://doi.org/10.1038/nature13178

   • PubMed
   • Google Scholar
7. 1. Felmer B
   2. Warren RD
   3. Barrett MP
   4. Cisek K
   5. Das A
   6. Jeffery IB
   7. Hurley E
   8. O’Riordain M
   9. Shanahan F
   10. O’Toole PW

   (2018) The oral microbiota is distinctive and predictive

   Gut 67:1454–1463.

   https://doi.org/10.1136/gutjnl-2017-314814

   • Google Scholar
8. 1. Ferretti P
   2. Pasolli E
   3. Tett A
   4. Asnicar F
   5. Gorfer V
   6. Fedi S
   7. Armanini F
   8. Truong DT
   9. Manara S
   10. Zolfo M
   11. Beghini F
   12. Bertorelli R
   13. De Sanctis V
   14. Bariletti I
   15. Canto R
   16. Clementi R
   17. Cologna M
   18. Crifò T
   19. Cusumano G
   20. Gottardi S
   21. Innamorati C
   22. Masè C
   23. Postai D
   24. Savoi D
   25. Duranti S
   26. Lugli GA
   27. Mancabelli L
   28. Turroni F
   29. Ferrario C
   30. Milani C
   31. Mangifesta M
   32. Anzalone R
   33. Viappiani A
   34. Yassour M
   35. Vlamakis H
   36. Xavier R
   37. Collado CM
   38. Koren O
   39. Tateo S
   40. Soffiati M
   41. Pedrotti A
   42. Ventura M
   43. Huttenhower C
   44. Bork P
   45. Segata N

   (2018) Mother-to-Infant microbial transmission from different body sites shapes the developing infant gut microbiome

   Cell Host & Microbe 24:133–145.

   https://doi.org/10.1016/j.chom.2018.06.005

   • PubMed
   • Google Scholar
9. 1. Flynn KJ
   2. Baxter NT
   3. Schloss PD

   (2016) Metabolic and community synergy of oral bacteria in colorectal cancer

   mSphere 1:e00102.

   https://doi.org/10.1128/mSphere.00102-16

   • PubMed
   • Google Scholar
10. 1. Franzosa EA
    2. Morgan XC
    3. Segata N
    4. Waldron L
    5. Reyes J
    6. Earl AM
    7. Giannoukos G
    8. Boylan MR
    9. Ciulla D
    10. Gevers D
    11. Izard J
    12. Garrett WS
    13. Chan AT
    14. Huttenhower C

    (2014) Relating the metatranscriptome and metagenome of the human gut

    PNAS 111:E2329–E2338.

    https://doi.org/10.1073/pnas.1319284111

    • PubMed
    • Google Scholar
11. 1. Gevers D
    2. Kugathasan S
    3. Denson LA
    4. Vázquez-Baeza Y
    5. Van Treuren W
    6. Ren B
    7. Schwager E
    8. Knights D
    9. Song SJ
    10. Yassour M
    11. Morgan XC
    12. Kostic AD
    13. Luo C
    14. González A
    15. McDonald D
    16. Haberman Y
    17. Walters T
    18. Baker S
    19. Rosh J
    20. Stephens M
    21. Heyman M
    22. Markowitz J
    23. Baldassano R
    24. Griffiths A
    25. Sylvester F
    26. Mack D
    27. Kim S
    28. Crandall W
    29. Hyams J
    30. Huttenhower C
    31. Knight R
    32. Xavier RJ

    (2014) The treatment-naive microbiome in new-onset crohn's disease

    Cell Host & Microbe 15:382–392.

    https://doi.org/10.1016/j.chom.2014.02.005

    • PubMed
    • Google Scholar
12. 1. Giannella RA
    2. Broitman SA
    3. Zamcheck N

    (1972) Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro

    Gut 13:251–256.

    https://doi.org/10.1136/gut.13.4.251

    • PubMed
    • Google Scholar
13. 1. Hajishengallis G

    (2015) Periodontitis: from microbial immune subversion to systemic inflammation

    Nature Reviews Immunology 15:30–44.

    https://doi.org/10.1038/nri3785

    • PubMed
    • Google Scholar
14. 1. Heintz-Buschart A
    2. May P
    3. Laczny CC
    4. Lebrun LA
    5. Bellora C
    6. Krishna A
    7. Wampach L
    8. Schneider JG
    9. Hogan A
    10. de Beaufort C
    11. Wilmes P

    (2016) Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes

    Nature Microbiology 2:16180.

    https://doi.org/10.1038/nmicrobiol.2016.180

    • PubMed
    • Google Scholar
15. 1. Howden CW
    2. Hunt RH

    (1987) Relationship between gastric secretion and infection

    Gut 28:96–107.

    https://doi.org/10.1136/gut.28.1.96

    • PubMed
    • Google Scholar
16. 1. Huerta-Cepas J
    2. Serra F
    3. Bork P

    (2016) ETE 3: reconstruction, analysis, and visualization of phylogenomic data

    Molecular Biology and Evolution 33:1635–1638.

    https://doi.org/10.1093/molbev/msw046

    • PubMed
    • Google Scholar
17. 1. Humphrey SP
    2. Williamson RT

    (2001) A review of saliva: normal composition, flow, and function

    The Journal of Prosthetic Dentistry 85:162–169.

    https://doi.org/10.1067/mpr.2001.113778

    • PubMed
    • Google Scholar
18. 1. Imhann F
    2. Bonder MJ
    3. Vich Vila A
    4. Fu J
    5. Mujagic Z
    6. Vork L
    7. Tigchelaar EF
    8. Jankipersadsing SA
    9. Cenit MC
    10. Harmsen HJ
    11. Dijkstra G
    12. Franke L
    13. Xavier RJ
    14. Jonkers D
    15. Wijmenga C
    16. Weersma RK
    17. Zhernakova A

    (2016) Proton pump inhibitors affect the gut microbiome

    Gut 65:740–748.

    https://doi.org/10.1136/gutjnl-2015-310376

    • PubMed
    • Google Scholar
19. 1. Jones DT
    2. Taylor WR
    3. Thornton JM

    (1992) The rapid generation of mutation data matrices from protein sequences

    Bioinformatics 8:275–282.

    https://doi.org/10.1093/bioinformatics/8.3.275

    • Google Scholar
20. 1. Korpela K
    2. Costea P
    3. Coelho LP
    4. Kandels-Lewis S
    5. Willemsen G
    6. Boomsma DI
    7. Segata N
    8. Bork P

    (2018) Selective maternal seeding and environment shape the human gut microbiome

    Genome Research 28:561–568.

    https://doi.org/10.1101/gr.233940.117

    • PubMed
    • Google Scholar
21. 1. Kultima JR
    2. Coelho LP
    3. Forslund K
    4. Huerta-Cepas J
    5. Li SS
    6. Driessen M
    7. Voigt AY
    8. Zeller G
    9. Sunagawa S
    10. Bork P

    (2016) MOCAT2: a metagenomic assembly, annotation and profiling framework

    Bioinformatics 32:2520–2523.

    https://doi.org/10.1093/bioinformatics/btw183

    • PubMed
    • Google Scholar
22. 1. Letunic I
    2. Bork P

    (2016) Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees

    Nucleic Acids Research 44:W242–W245.

    https://doi.org/10.1093/nar/gkw290

    • PubMed
    • Google Scholar
23. 1. Li H
    2. Durbin R

    (2009) Fast and accurate short read alignment with Burrows-Wheeler transform

    Bioinformatics 25:1754–1760.

    https://doi.org/10.1093/bioinformatics/btp324

    • PubMed
    • Google Scholar
24. 1. Li SS
    2. Zhu A
    3. Benes V
    4. Costea PI
    5. Hercog R
    6. Hildebrand F
    7. Huerta-Cepas J
    8. Nieuwdorp M
    9. Salojärvi J
    10. Voigt AY
    11. Zeller G
    12. Sunagawa S
    13. de Vos WM
    14. Bork P

    (2016) Durable coexistence of donor and recipient strains after fecal microbiota transplantation

    Science 352:586–589.

    https://doi.org/10.1126/science.aad8852

    • PubMed
    • Google Scholar
25. 1. Liu Y
    2. Zhang Y
    3. Dong P
    4. An R
    5. Xue C
    6. Ge Y
    7. Wei L
    8. Liang X

    (2015) Digestion of nucleic acids starts in the stomach

    Scientific Reports 5:11936.

    https://doi.org/10.1038/srep11936

    • PubMed
    • Google Scholar
26. 1. Lloyd-Price J
    2. Mahurkar A
    3. Rahnavard G
    4. Crabtree J
    5. Orvis J
    6. Hall AB
    7. Brady A
    8. Creasy HH
    9. McCracken C
    10. Giglio MG
    11. McDonald D
    12. Franzosa EA
    13. Knight R
    14. White O
    15. Huttenhower C

    (2017) Strains, functions and dynamics in the expanded Human Microbiome Project

    Nature 486:207.

    https://doi.org/10.1038/nature23889

    • Google Scholar
27. 1. Lynch SV
    2. Pedersen O

    (2016) The human intestinal microbiome in health and disease

    New England Journal of Medicine 375:2369–2379.

    https://doi.org/10.1056/NEJMra1600266

    • PubMed
    • Google Scholar
28. 1. Martinsen TC
    2. Bergh K
    3. Waldum HL

    (2005) Gastric juice: a barrier against infectious diseases

    Basic Clin Pharmacol Toxicol 96:94–102.

    https://doi.org/10.1111/j.1742-7843.2005.pto960202.x

    • PubMed
    • Google Scholar
29. 1. Mende DR
    2. Sunagawa S
    3. Zeller G
    4. Bork P

    (2013) Accurate and universal delineation of prokaryotic species

    Nature Methods 10:881–884.

    https://doi.org/10.1038/nmeth.2575

    • PubMed
    • Google Scholar
30. 1. Mercer DK
    2. Scott KP
    3. Bruce-Johnson WA
    4. Glover LA
    5. Flint HJ

    (1999)

    Fate of free DNA and transformation of the oral bacterium streptococcus gordonii DL1 by plasmid DNA in human saliva

    Applied and Environmental Microbiology 65:6–10.

    • PubMed
    • Google Scholar
31. Software

    1. Oksanen J
    2. Blanchet FG
    3. Kindt R
    4. Legendre P
    5. Minchin PR
    6. O’Hara RB
    7. Simpson GL
    8. Solymos P
    9. Stevens MHS
    10. Wagner H

    (2015)

    Vegan: Community Ecology Package

    R Package.
32. Software

    1. Orme D
    2. Freckleton R
    3. Thomas G
    4. Petzoldt T
    5. Fritz S
    6. Isaac N
    7. Pearse W

    (2018)

    Caper: comparative analyses of phylogenetics and evolution in R

    R Development Core Team.
33. 1. Price MN
    2. Dehal PS
    3. Arkin AP

    (2010) FastTree 2--approximately maximum-likelihood trees for large alignments

    PLOS ONE 5:e9490.

    https://doi.org/10.1371/journal.pone.0009490

    • PubMed
    • Google Scholar
34. 1. Ridlon JM
    2. Kang DJ
    3. Hylemon PB
    4. Bajaj JS

    (2014) Bile acids and the gut microbiome

    Current Opinion in Gastroenterology 30:332–338.

    https://doi.org/10.1097/MOG.0000000000000057

    • PubMed
    • Google Scholar
35. 1. Savage DC

    (1977) Microbial ecology of the gastrointestinal tract

    Annual Review of Microbiology 31:107–133.

    https://doi.org/10.1146/annurev.mi.31.100177.000543

    • PubMed
    • Google Scholar
36. 1. Schloissnig S
    2. Arumugam M
    3. Sunagawa S
    4. Mitreva M
    5. Tap J
    6. Zhu A
    7. Waller A
    8. Mende DR
    9. Kultima JR
    10. Martin J
    11. Kota K
    12. Sunyaev SR
    13. Weinstock GM
    14. Bork P

    (2013) Genomic variation landscape of the human gut microbiome

    Nature 493:45–50.

    https://doi.org/10.1038/nature11711

    • PubMed
    • Google Scholar
37. 1. Schmidt TSB
    2. Matias Rodrigues JF
    3. von Mering C

    (2017) A family of interaction-adjusted indices of community similarity

    The ISME Journal 11:791–807.

    https://doi.org/10.1038/ismej.2016.139

    • Google Scholar
38. 1. Schmidt TSB
    2. Raes J
    3. Bork P

    (2018) The Human Gut Microbiome: From Association to Modulation

    Cell 172:1198–1215.

    https://doi.org/10.1016/j.cell.2018.02.044

    • PubMed
    • Google Scholar
39. 1. Segata N
    2. Haake SK
    3. Mannon P
    4. Lemon KP
    5. Waldron L
    6. Gevers D
    7. Huttenhower C
    8. Izard J

    (2012) Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples

    Genome Biology 13:R42.

    https://doi.org/10.1186/gb-2012-13-6-r42

    • PubMed
    • Google Scholar
40. 1. Sender R
    2. Fuchs S
    3. Milo R

    (2016) Revised estimates for the number of human and bacteria cells in the body

    PLOS Biology 14:e1002533.

    https://doi.org/10.1371/journal.pbio.1002533

    • PubMed
    • Google Scholar
41. 1. Sievers F
    2. Wilm A
    3. Dineen D
    4. Gibson TJ
    5. Karplus K
    6. Li W
    7. Lopez R
    8. McWilliam H
    9. Remmert M
    10. Soding J
    11. Thompson JD
    12. Higgins DG

    (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega

    Molecular Systems Biology 7:539.

    https://doi.org/10.1038/msb.2011.75

    • Google Scholar
42. 1. Socransky SS
    2. Haffajee AD
    3. Cugini MA
    4. Smith C
    5. Kent RL

    (1998) Microbial complexes in subgingival plaque

    Journal of Clinical Periodontology 25:134–144.

    https://doi.org/10.1111/j.1600-051X.1998.tb02419.x

    • PubMed
    • Google Scholar
43. 1. Tibshirani R

    (1996) Regression shrinkage and selection via the lasso

    Journal of the Royal Statistical Society: Series B 58:267–288.

    https://doi.org/10.1111/j.2517-6161.1996.tb02080.x

    • Google Scholar
44. 1. Voigt AY
    2. Costea PI
    3. Kultima JR
    4. Li SS
    5. Zeller G
    6. Sunagawa S
    7. Bork P

    (2015) Temporal and technical variability of human gut metagenomes

    Genome Biology 16:1.

    https://doi.org/10.1186/s13059-015-0639-8

    • PubMed
    • Google Scholar
45. 1. Wade WG

    (2013) The oral microbiome in health and disease

    Pharmacological Research 69:137–143.

    https://doi.org/10.1016/j.phrs.2012.11.006

    • PubMed
    • Google Scholar
46. 1. Wattam AR
    2. Davis JJ
    3. Assaf R
    4. Boisvert S
    5. Brettin T
    6. Bun C
    7. Conrad N
    8. Dietrich EM
    9. Disz T
    10. Gabbard JL
    11. Gerdes S
    12. Henry CS
    13. Kenyon RW
    14. Machi D
    15. Mao C
    16. Nordberg EK
    17. Olsen GJ
    18. Murphy-Olson DE
    19. Olson R
    20. Overbeek R
    21. Parrello B
    22. Pusch GD
    23. Shukla M
    24. Vonstein V
    25. Warren A
    26. Xia F
    27. Yoo H
    28. Stevens RL

    (2017) Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center

    Nucleic Acids Research 45:D535–D542.

    https://doi.org/10.1093/nar/gkw1017

    • PubMed
    • Google Scholar
47. 1. Zeller G
    2. Tap J
    3. Voigt AY
    4. Sunagawa S
    5. Kultima JR
    6. Costea PI
    7. Amiot A
    8. Böhm J
    9. Brunetti F
    10. Habermann N
    11. Hercog R
    12. Koch M
    13. Luciani A
    14. Mende DR
    15. Schneider MA
    16. Schrotz-King P
    17. Tournigand C
    18. Tran Van Nhieu J
    19. Yamada T
    20. Zimmermann J
    21. Benes V
    22. Kloor M
    23. Ulrich CM
    24. von Knebel Doeberitz M
    25. Sobhani I
    26. Bork P

    (2014) Potential of fecal microbiota for early-stage detection of colorectal cancer

    Molecular Systems Biology 10:766.

    https://doi.org/10.15252/msb.20145645

    • PubMed
    • Google Scholar
48. 1. Zhang X
    2. Zhang D
    3. Jia H
    4. Feng Q
    5. Wang D
    6. Liang D
    7. Wu X
    8. Li J
    9. Tang L
    10. Li Y
    11. Lan Z
    12. Chen B
    13. Li Y
    14. Zhong H
    15. Xie H
    16. Jie Z
    17. Chen W
    18. Tang S
    19. Xu X
    20. Wang X
    21. Cai X
    22. Liu S
    23. Xia Y
    24. Li J
    25. Qiao X
    26. Al-Aama JY
    27. Chen H
    28. Wang L
    29. Wu QJ
    30. Zhang F
    31. Zheng W
    32. Li Y
    33. Zhang M
    34. Luo G
    35. Xue W
    36. Xiao L
    37. Li J
    38. Chen W
    39. Xu X
    40. Yin Y
    41. Yang H
    42. Wang J
    43. Kristiansen K
    44. Liu L
    45. Li T
    46. Huang Q
    47. Li Y
    48. Wang J

    (2015) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

    Nature Medicine 21:895–905.

    https://doi.org/10.1038/nm.3914

    • PubMed
    • Google Scholar
49. 1. Zmora N
    2. Zilberman-Schapira G
    3. Suez J
    4. Mor U
    5. Dori-Bachash M
    6. Bashiardes S
    7. Kotler E
    8. Zur M
    9. Regev-Lehavi D
    10. Brik RB
    11. Federici S
    12. Cohen Y
    13. Linevsky R
    14. Rothschild D
    15. Moor AE
    16. Ben-Moshe S
    17. Harmelin A
    18. Itzkovitz S
    19. Maharshak N
    20. Shibolet O
    21. Shapiro H
    22. Pevsner-Fischer M
    23. Sharon I
    24. Halpern Z
    25. Segal E
    26. Elinav E

    (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features

    Cell 174:1388–1405.

    https://doi.org/10.1016/j.cell.2018.08.041

    • PubMed
    • Google Scholar

Author details

1. Thomas SB Schmidt

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Contribution

   Conceptualization, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing

   Contributed equally with

   Matthew R Hayward

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-8587-4177

2. Matthew R Hayward

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Present address

   The Ragon Institute of MGH, MIT and Harvard, Cambridge, United States

   Contribution

   Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Writing—original draft, Writing—review and editing

   Contributed equally with

   Thomas SB Schmidt

   Competing interests

   No competing interests declared

3. Luis P Coelho

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Present address

   Institute of Science and Technology for Brain-Inspired Intelligence (ISTBI), Fudan University, Shanghai, China

   Contribution

   Conceptualization, Software, Methodology, Writing—review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-9280-7885

4. Simone S Li

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Present address

   Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark

   Contribution

   Conceptualization, Methodology, Writing—review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-0073-3656

5. Paul I Costea

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Contribution

   Conceptualization, Methodology

   Competing interests

   No competing interests declared

6. Anita Y Voigt

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Present address

   The Jackson Laboratory for Genomic Medicine, Connecticut, United States

   Contribution

   Resources, Investigation

   Competing interests

   No competing interests declared

7. Jakob Wirbel

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Contribution

   Formal analysis, Visualization, Writing—review and editing

   Competing interests

   No competing interests declared

8. Oleksandr M Maistrenko

   Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

   Contribution

   Resources, Investigation, Writing—review and editing

   Competing interests

   No competing interests declared

9. Renato JC Alves

   1. Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
   2. Joint PhD programme, European Molecular Biology Laboratory and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany

   Contribution

   Data curation, Investigation

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-7212-0234

10. Emma Bergsten

    Department of Gastroenterology and EA7375 -EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France

    Contribution

    Investigation, Writing—review and editing

    Competing interests

    No competing interests declared

11. Carine de Beaufort

    1. Luxembourg Centre for Systems Biomedicine, Luxembourg, Luxembourg
    2. Clinique Pédiatrique, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg

    Contribution

    Resources, Data curation

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0003-4310-6799

12. Iradj Sobhani

    Department of Gastroenterology and EA7375 -EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France

    Contribution

    Resources, Data curation

    Competing interests

    No competing interests declared

13. Anna Heintz-Buschart

    Luxembourg Centre for Systems Biomedicine, Luxembourg, Luxembourg

    Present address

    Department of Soil Ecology, Helmholtz Centre for Environmental Research - UFZ, Halle, Germany

    Contribution

    Resources, Data curation, Investigation, Writing—review and editing

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-9780-1933

14. Shinichi Sunagawa

    Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

    Present address

    Department of Biology, ETH Zürich, Zürich, Switzerland

    Contribution

    Conceptualization, Supervision, Project administration, Writing—review and editing

    Competing interests

    No competing interests declared

15. Georg Zeller

    Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany

    Contribution

    Supervision, Funding acquisition, Methodology, Writing—review and editing

    Competing interests

    No competing interests declared

16. Paul Wilmes

    Luxembourg Centre for Systems Biomedicine, Luxembourg, Luxembourg

    Contribution

    Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and editing

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-6478-2924

17. Peer Bork

    1. Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
    2. Max Delbrück Centre for Molecular Medicine, Berlin, Germany
    3. Molecular Medicine Partnership Unit (MMPU), European Molecular Biology Laboratory and University Hospital Heidelberg, Heidelberg, Germany
    4. Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany

    Contribution

    Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing—original draft, Project administration, Writing—review and editing

    For correspondence

    bork@embl.de

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-2627-833X

• 14,590

  views

• 2,216

  downloads

• 379

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.